Related Articles
Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer
The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer
Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma
SNS-032 prevents hypoxia-mediated glioblastoma cell invasion by inhibiting hypoxia inducible factor-1α expression